News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
539 Results
Type
Article (130)
Company Profile (1)
Press Release (408)
Section
Business (189)
Deals (22)
Drug Development (33)
FDA (13)
Job Trends (39)
News (227)
Policy (16)
Tag
Academia (7)
Alliances (42)
Alzheimer's disease (1)
Approvals (13)
Artificial intelligence (1)
Bankruptcy (2)
Best Places to Work (32)
Biotechnology (1)
Cancer (6)
Cell therapy (1)
Clinical research (24)
Collaboration (2)
Compensation (1)
COVID-19 (6)
C-suite (2)
Data (4)
Diagnostics (15)
Earnings (41)
Events (38)
FDA (13)
Funding (3)
Gene therapy (1)
Government (2)
Healthcare (11)
Immunology and inflammation (1)
Infectious disease (6)
IPO (14)
Job creations (7)
Layoffs (5)
Legal (4)
Lung cancer (3)
Medical device (4)
Medtech (4)
Mergers & acquisitions (18)
Neuroscience (3)
NextGen: Class of 2026 (12)
Non-profit (5)
Opinion (2)
People (79)
Phase I (12)
Phase II (10)
Phase III (6)
Pipeline (1)
Postmarket research (1)
Preclinical (4)
Rare diseases (1)
Real estate (3)
Regulatory (11)
Research institute (12)
Schizophrenia (1)
Series A (1)
Series B (1)
Sickle cell disease (1)
Startups (22)
The Weekly (1)
Venture capital (1)
Date
Last 30 days (1)
Last 365 days (25)
2025 (25)
2024 (56)
2023 (37)
2022 (62)
2021 (54)
2020 (22)
2019 (51)
2018 (55)
2017 (25)
2016 (35)
2015 (42)
2014 (19)
2013 (13)
2012 (16)
2011 (6)
2010 (5)
Location
Africa (2)
Asia (11)
Australia (5)
California (34)
Europe (36)
Maryland (1)
New York (6)
Northern California (24)
Pennsylvania (1)
South America (2)
Southern California (2)
United States (43)
Washington State (1)
539 Results for "23andme".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Regeneron Comes to 23andMe’s Rescue With $256M Acquisition Plan
Regeneron promised to comply with 23andMe’s consumer privacy policies and related data security laws.
May 19, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Regeneron Backs Off 23andMe, Losing Bid to Former CEO
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” according to a spokesperson for the pharma.
June 16, 2025
·
2 min read
·
Tristan Manalac
Press Releases
23andMe Research Institute Appoints John McLeod General Counsel and Chief Risk Officer
December 10, 2025
·
2 min read
Press Releases
23andMe Research Institute Appoints Privacy Advisory Board
October 31, 2025
·
3 min read
Press Releases
23andMe Research Institute Appoints Kael Reicin as Chief Financial Officer
November 6, 2025
·
2 min read
Press Releases
23andMe Research Institute Helps Reconnect African Diaspora to Their Roots with Release of 250+ High-Resolution African Genetic Groups
November 21, 2025
·
4 min read
Press Releases
23andMe Research Institute Names Brad Margus and Stephen Quake, D.Phil., to Board of Directors
October 27, 2025
·
3 min read
Layoffs
23andMe Cuts Headcount by 40%, Drops Drug Discovery Work
In line with the restructuring initiative, 23andMe is looking for strategic opportunities for its pipeline assets, including licensing deals or outright sales.
November 12, 2024
·
2 min read
·
Tristan Manalac
Press Releases
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
May 27, 2025
·
4 min read
Press Releases
23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation
June 30, 2025
·
6 min read
1 of 54
Next
